Tizanidne Hydrochloride Capsule
Product Images NDC 63629-8871

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 63629-8871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298871)

Label for Tizanidine Hydrochloride Capsules, 2 mg from Bryant Ranch Prepack. The label displays the NDC 63629-8871-1 and indicates an oral capsule dosage form available in a 150-capsule count package. The label also includes storage instructions, a barcode, and the BRP Pharmaceuticals logo.*

FDA Label Image

Tiz01 (Tiz01)

Chemical structure of Tizanidine Hydrochloride, showing its molecular framework including a chlorine atom, nitrogen atoms, sulfur atom, and hydrochloride (HCl) component.*

FDA Label Image

Tiz02 (Tiz02)

A pharmacokinetic graph showing plasma Tizanidine concentration (ng/mL) over 24 hours after dosing. The plot compares four scenarios: 2 x 4 mg Tizanidine tablets with food, 2 x 4 mg tablets without food, 2 x 4 mg capsules with food, and 2 x 4 mg capsules without food, illustrating concentration changes over time for each.*

FDA Label Image

Tiz03 (Tiz03)

A line graph showing improvement in Ashworth Score over hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis represents improvement, and the horizontal axis represents time in hours post-dose. Data points include error bars for variability.*

FDA Label Image

Tiz04 (Tiz04)

A chart showing improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) versus placebo. The X-axis marks time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The Y-axis represents improvement, with tizanidine demonstrating greater improvement than placebo at each time point, including error bars.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.